Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 4
Submit an article Journal homepage
142
Views
6
CrossRef citations to date
0
Altmetric
Letter to the Editor

Successful treatment with reduced-intensity cord blood transplant in a patient with relapsed refractory hepatosplenic T-cell lymphoma

Masahiko SumiDepartment of Hematology, Nagano Red Cross Hospital, Nagano, JapanCorrespondence[email protected]
,
Wataru TakedaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Hiroko KaiumeDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Takehiko KiriharaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Taro KuriharaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Keijiro SatoDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Toshimitsu UekiDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Yuki HiroshimaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Mayumi UenoDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
,
Naoaki IchikawaDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
&
Hikaru KobayashiDepartment of Hematology, Nagano Red Cross Hospital, Nagano, Japan
 show all
Pages 1140-1142 | Received 10 Jul 2014, Accepted 16 Jul 2014, Published online: 19 Aug 2014

References

  • Vose J, Armitage J, Weisenburger D; International T-Cell Lymphoma Project. International peripheral T-cell and natural killer/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 2008;26:4124–4130.
  • Gaulard P, Jaffe ES, Krenacs L, et al. Hepatosplenic T-cell lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008. pp 292–293.
  • Visnyei K, Grossbard ML, Shapira I. Hepatosplenic γδ T-cell lymphoma: an overview. Clin Lymphoma Myeloma Leuk 2013;13: 360–369.
  • Ferreri AJ, Govi S, Pileri SA. Hepatosplenic gamma-delta T-cell lymphoma. Crit Rev Oncol Hematol 2012;83:283–292.
  • Falchook GS, Vega F, Dang NH, et al. Hepatosplenic gamma-delta T-cell lymphoma:clinicopathological features and treatment. Ann Oncol 2009;20:1080–1085.
  • Belhadj K, Reyes F, Farcet JP, et al. Hepatosplenic gammadelta T-cell lymphoma is a rare clinicopathologic entity with poor outcome:report on a series of 21 patients. Blood 2003;102:4261–4269.
  • Chanan-Khan A, Islam T, Alam A, et al. Long-term survival with allogeneic stem cell transplant and donor lymphocyte infusion following salvage therapy with anti-CD52 monoclonal antibody (Campath) in a patient with alpha/beta hepatosplenic T-cell non-Hodgkin's lymphoma. Leuk Lymphoma 2004;45:1673–1675.
  • Voss MH, Lunning MA, Maragulia JC, et al. Intensive induction chemotherapy followed by early high-dose therapy and hematopoietic stem cell transplantation results in improved outcome for patients with hepatosplenic T-cell lymphoma: a single institution experience. Clin Lymphoma Myeloma Leuk 2013;13:8–14.
  • He S, Roberts A, Ritchie D, et al. Graft-versus-lymphoma effect in progressive hepatosplenic gamma/delta T-cell lymphoma. Leuk Lymphoma 2007;48:1448–1450.
  • Sakai R, Fujisawa S, Fujimaki K, et al. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma after cord blood stem cell transplantation following autologous peripheral blood stem cell transplantation. Bone Marrow Transplant 2006;37:537–538.
  • Konuma T, Ooi J, Takahashi S, et al. Allogeneic stem cell transplantation for hepatosplenic gammadelta T-cell lymphoma. Leuk Lymphoma 2007;48:630–632.
  • Bašić Kinda S, Duraković N, Dotlić S, et al. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant. Leuk Lymphoma 2013;54:1334–1335.
  • Chalmers AW, Katz DA, Miller IJ, et al. Successful treatment of hepatosplenic T-cell lymphoma with ESHAP followed by autologous stem cell transplant. Clin Adv Hematol Oncol 2013;11:109–113.
  • Otrock ZK, Hatoum HA, Salem ZM, et al. Long-term remission in a patient with hepatosplenic gammadelta T cell lymphoma treated with bortezomib and high-dose CHOP-like chemotherapy followed by autologous peripheral stem cell transplantation. Ann Hematol 2008;87:1023–1024.
  • Corazzelli G, Capobianco G, Russo F, et al. Pentostatin (2’-deoxycoformycin) for the treatment of hepatosplenic gammadelta T-cell lymphomas. Haematologica 2005;90:ECR14.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.